Global attention to the vulnerability of the pharma distribution
Covid-19 has drawn the world's attention - far beyond the healthcare world - to the need to control the pharma cold supply chain. The model has been to produce drugs and send them to their destination for distribution – and that was it. Carriers of course have protocols and safety requirements to follow, but they have hardly been subjected to the type of review and follow-up that emerged with COVID-19. As with many other parts of our world, COVID-19 has shown both the vulnerability of our way of life and the power of a well-functioning supply chain. Many actors seriously question whether the supply chain in general meets the regulatory, medical or market requirements that have been set. And in formal audits, problems have been exposed.
We go beyond current limitations
Our versatile system can monitor your biological products
We go beyond current limitations
- 20% of temperature-sensitive medicine is damaged during transport due to a broken cold chain.
- 25% of vaccines reach their target degraded due to incorrect delivery.
- Vaccines worth $ 6.6 billion is discarded annually due to lack of temperature control.
- Even worse is that vaccines are given with insufficient or no function at all.
Currently used solutions to solve and control the cold chain include:
Means: Deep freezers, refrigerators, Dry ice/CO2 packaging, cold carriers, temperature-controlled air cargo containers.
Control: Local temperature gauge monitoring, dataloggers attached to parcels, connected dataloggers - Seldom used through the whole supply chain.
Don't trust your gut.
Traditional cold chain monitoring equipment not enough:
- Logistics and healthcare providers can not immediately access whether a medicine is usable, because current loggers and devices require a special audit later by trained quality staff or specialized physicians.
- This leads to losses when medicines that in fact still have "shelf time" are discarded unnecessarily.
- It also leads to illegitimate use of medicines, such as vaccines, that no longer have the medical properties to effectively help patients.
- Tridentify goes beyond gut feeling.
Third party logistics? Care facility, hospital, patient? Whatever role or accountability in the supply chain, with the patented Tridentify QTA system you can rest assured that the pharma can be used safely within the timeframe from leaving the manufacturers warehouse to the end user by relying on the continuous feedback from the QTA system. This is not an advanced so called “logger” but a medical device Class IIa system. Hence, Tridentify’s origin, core and standard level are not from a logistical point of view - but from a medical technology and human safety point of view.
Beyond predictive analytics
Tridentify delivers an advanced SaaS system connecting to IoT tracers, able to overcome the limitations of the current available logging technologies. Unlike other solutions, Tridentify’s patented QTA tracer is configured down to an organizational level, to the exact specifications of the sensitive goods. This gives it the ability to communicate the remaining shelf life of the individual package in real-time. Our QTA system is easy to implement with no intrusive IT integration thanks to it’s SaaS architecture. However, the data can easily be exported to be used in other systems. We are confident that we have the best technical solution for Pharmaceuticals that meets both current and tightening future regulatory requirements. The system can be programmed in detail for all parameters. In practice, adaptations may be needed, so please contact us to discuss a solution according to your specific needs.
Remember! Tridentify QTA is the only certified Medical Device (IIa) system for Quality Control in BioPharma Logistics
A strong trend, which after Covid 19 exploded on to the scene, is home deliveries of medicine. It includes patient-critical medicine that requires extra care, temperature control, and precise delivery times. The patient benefits from not having to visit a pharmacy - perhaps carrying a cooler bag - or even their care facility or hospital which is not necessarily nearby. By using Tridentify QTA both the supplier, distributor and end-user benefits. The quality and usability of the preparation is 100% guaranteed upon delivery to the patient’s doorstep.
Surgeons may have to go themselves to hospitals to collect and transport hearts, which survive only four to six hours outside the body. But kidneys and pancreases — which have longer shelf lives — often travel commercially, as cargo. As such, they can end up missing connecting flights or get delayed like lost luggage. Worse still, the cool boxes used are typically tracked with a primitive system of phone calls and paper manifests without proper electronic tracking or temperature/movement monitoring. Using a proper MedTech system such as Tridentify may increase the graft survival rate — the percentage of patients who have functioning transplanted organs at a certain point in time — or secure that the patient actually receives a functioning kidney as planned.
The global pharma supply chain
An important trend that existed before the pandemic was also the globalization of raw materials and inputs for pharmaceutical production. Many of which very sensitive to temperature fluctuations and external influences. COVID-19 has also shed light on how drug production typically happens today. Raw materials can be imported from China, a medicinal crop is grown and harvested in Australia, collaborated in India, combined with other ingredients to form a final drug at a plant in France before the drug is distributed to hospitals or pharmacies in Europe and the USA. Using MedTech from Tridentify ensures both the supplier, the intermediary, and subcontractors that all inputs are of the intended quality before final production.
"The Tridentify QTA system is easy to implement with no intrusive IT integration thanks to it’s SaaS architecture. However, the data can easily be exported to be used in other systems."